JM Research   Report issue

For profit Phase 3
Founded: Vista Hermosa Mexico (2004)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2018
NCT03696940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

JM Research, SC

Active Ingredients

Drugs in Phase 3 Trials (2)

atorvastatin (lipitor) (1 trial)

levocarnitine (carnitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2